Great West Life Assurance Co. Can decreased its position in shares of Xylem Inc. (NYSE:XYL) by 0.4% during the second quarter, Holdings Channel reports. The institutional investor owned 125,660 shares of the industrial products company’s stock after selling 497 shares during the period. Great West Life Assurance Co. Can’s holdings in Xylem were worth $6,956,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Asset Planning Services Ltd. increased its position in shares of Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock worth $106,000 after buying an additional 7 shares in the last quarter. Cribstone Capital Management LLC increased its position in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock worth $124,000 after buying an additional 2,247 shares in the last quarter. CENTRAL TRUST Co increased its position in shares of Xylem by 160.3% in the second quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock worth $146,000 after buying an additional 1,635 shares in the last quarter. FNY Partners Fund LP purchased a new position in Xylem during the first quarter worth about $151,000. Finally, Pacer Advisors Inc. increased its position in Xylem by 3.4% in the first quarter. Pacer Advisors Inc. now owns 3,701 shares of the industrial products company’s stock worth $186,000 after buying an additional 121 shares during the period. Institutional investors own 86.41% of the company’s stock.

Xylem Inc. (NYSE:XYL) opened at 59.12 on Friday. Xylem Inc. has a one year low of $45.60 and a one year high of $60.71. The company has a market capitalization of $10.62 billion, a P/E ratio of 38.17 and a beta of 1.18. The stock’s 50 day moving average price is $56.81 and its 200 day moving average price is $51.96.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, August 1st. The industrial products company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.02. Xylem had a return on equity of 16.02% and a net margin of 7.08%. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the prior year, the business earned $0.48 EPS. The business’s revenue for the quarter was up 24.9% compared to the same quarter last year. Equities analysts anticipate that Xylem Inc. will post $2.37 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was originally published by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.watchlistnews.com/xylem-inc-xyl-position-lowered-by-great-west-life-assurance-co-can/1480573.html.

XYL has been the subject of a number of research reports. CIBC reiterated a “buy” rating on shares of Xylem in a report on Wednesday, May 10th. Oppenheimer Holdings, Inc. reiterated a “buy” rating on shares of Xylem in a report on Tuesday, May 9th. Zacks Investment Research upgraded Xylem from a “hold” rating to a “buy” rating and set a $62.00 price objective for the company in a report on Tuesday, July 4th. BidaskClub upgraded Xylem from a “hold” rating to a “buy” rating in a report on Wednesday, June 28th. Finally, Boenning Scattergood reiterated a “buy” rating and issued a $55.00 price objective on shares of Xylem in a report on Wednesday, June 7th. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $59.00.

In other news, insider Kenneth Napolitano sold 9,052 shares of the business’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $60.16, for a total value of $544,568.32. Following the completion of the transaction, the insider now directly owns 35,303 shares of the company’s stock, valued at approximately $2,123,828.48. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Steven R. Loranger sold 66,132 shares of the business’s stock in a transaction on Thursday, June 29th. The stock was sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the transaction, the director now directly owns 65,030 shares of the company’s stock, valued at $3,577,300.30. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by corporate insiders.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.